The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvingtrans Regulatory News (AVG)

Share Price Information for Avingtrans (AVG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 425.00
Bid: 420.00
Ask: 430.00
Change: 7.50 (1.80%)
Spread: 10.00 (2.381%)
Open: 417.50
High: 425.00
Low: 417.50
Prev. Close: 417.50
AVG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

11 Dec 2012 07:01

AVINGTRANS PLC - Trading Update

AVINGTRANS PLC - Trading Update

PR Newswire

London, December 10

Avingtrans Plc ("Avingtrans" or the "Company" or the "Group") Trading Update

Avingtrans (AIM:AVG), a manufacturer of critical components and associatedservices to the global aerospace, energy and medical sectors is pleased toannounce an update on trading in light of the recent transactions completed bythe Group.

Summary of recent transactions (the "Recent Transactions")

On 5 November 2012, the Company announced the sale of Jena Tec, its Industrialdivision, for a cash consideration of £13.45m and we also set out a clearlydefined strategy focussed on the Group's two core divisions: Aerospace andEnergy & Medical.

In line with this strategy, the Company subsequently announced the acquisitionsof certain assets of PFW Farnborough ("PFW") for £1.85m (announced 16 November)and Aerotech Tubes ("Aerotech") for £2m (announced 26 November), which havepropelled the business into a leading position in Europe in the Aerospace pipesmarket.

The sale of Jena Tec, and the subsequent acquisitions described above, providesus with a more focused business, and a stronger balance sheet, which willenable us to invest in each of these businesses and pursue opportunities whichwe would otherwise have been unable to target. Consistent with this strategy,we will continue to seek further value enhancing acquisitions to build on theGroup's position in our core Aerospace and Energy & Medical divisions.

Outlook

2013 Financial Year

Sales Revenues for the year are expected to be in line with original Boardexpectations, with the loss of revenue replaced by revenue streams from PFW andAerotech in the second half of the 2013 financial year. However, in the shortterm, the margins realised from sales at PFW and Aerotech will not compensatefor the loss of margin in respect of Jena Tec, which will impact profitabilityfor the 2013 financial year.

The Group will realise an exceptional profit in respect of the disposal of JenaTec of approximately £8m and will incur exceptional costs of £0.35m in respectof the acquisitions of PFW and Aerotech.

Net debt for the full year will be materially lower than previous Boardexpectations, with the cash proceeds received from the disposal of Jena Tec,partially offset by the cash consideration in respect of the PFW and Aerotechacquisitions, further capital investment, particularly in respect of China, andthe immediate working capital requirements at PFW. However, we have chosen notto pay back all of the Group debt at this time - mortgages on properties andequipment leases being left mostly intact.

2014 Financial Year

The Board is confident that the Group will see both revenue and marginimprovement during the 2014 financial year, which will deliver resultsmarginally above previous Board expectations. Coupled with an improved and morerobust balance sheet, the Board believes that the recent transformationaltransactions place the Group in a much stronger position for the future, bothfinancially and strategically.

Interim dividend and results

Given the improved position of the Group, and to emphasise our confidence inthe future, the Board expects to reinstate an interim dividend of 0.7p when theCompany announces its results for the six months ended 30 November 2012.

The Company expects to release its interim results for the six months ended 30November 2012 in the week commencing 25 February 2013.

Enquiries:Avingtrans plc 0115 949 9020Steve McQuillan, CEOStephen King, CFO

Numis Securities Limited 020 7260 1000

David Poutney (Corporate Broking)

Richard Thomas (Corporate Finance and Nominated Adviser)

Newgate Threadneedle 020 7653 9850(Financial PR)Josh RoystonHeather ArmstrongAbout Avingtrans

Avingtrans plc is engaged in the provision of highly engineered components and services to the Aerospace, Energy and Medical markets worldwide.

The business is made up of 2 divisions:

Aerospace, engaged in the manufacture of rigid pipe assemblies, fabricationsand prismatic components - both metallic and composite - for the globalaerospace market and precision polishing of aircraft components and;

Energy and medical, engaged in the manufacture of machined and fabricatedpressure and vacuum vessels and components for the energy, medical, science andresearch communities. Plus, design and manufacture of fabricated poles andcabinets for roadside safety cameras and rail track signalling.

Date   Source Headline
26th Mar 202411:15 amRNSPDMR Dealings
21st Mar 20245:15 pmRNSExercise of Options, PDMR Dealings & TVR
20th Mar 20243:39 pmRNSHolding(s) in Company
4th Mar 20246:10 pmRNSPDMR Dealings
28th Feb 20247:00 amRNSInterim Results
18th Jan 20247:00 amRNSTrading Update and Notice of Results
15th Dec 20233:00 pmRNSExercise of Options & TVR
4th Dec 20237:00 amRNSMagnetica Limited appoints US distributor
22nd Nov 20237:00 amRNSEmployee & PDMR Share Incentive Awards
16th Nov 20232:20 pmRNSResult of AGM
13th Nov 20237:00 amRNSHayward Tyler Contract Win
11th Oct 20237:00 amRNSContract Wins
28th Sep 20235:54 pmRNSHolding(s) in Company
27th Sep 20237:00 amRNSPreliminary results for the year ended 31 May 2023
25th Sep 20237:00 amRNSHolding(s) in Company
18th Sep 20237:00 amRNSCompletion of Acquisition of Adaptix Ltd
4th Sep 20237:00 amRNSBoard Update
7th Aug 20237:00 amRNSAcquisition of Slack & Parr and Adaptix update
13th Jul 20237:00 amRNSTrading Update & Possible Acquisition of Adaptix
5th Jun 20237:00 amRNSBoard Changes
22nd Feb 20237:00 amRNSInterim Results
15th Feb 20237:00 amRNSAdaptix appoints Willem Baralt as new Chairman
30th Jan 20237:00 amRNSAdaptix secures 510(k) clearance from FDA
27th Jan 20231:19 pmRNSEmployee & PDMR Share Incentive Awards
23rd Jan 20236:12 pmRNSPDMR Dealings
18th Jan 20237:00 amRNSAdditional Investment in Magnetica
16th Jan 20237:00 amRNSTrading Update, Acquisitions and Notice of Results
23rd Dec 20228:30 amRNSExercise of Options, PDMR Dealings & TVR
14th Dec 20227:00 amRNSSteve McQuillan appointed as Chairman of Adaptix
17th Nov 20223:56 pmRNSResult of Annual General Meeting
28th Sep 20227:00 amRNSPreliminary results for the year ended 31 May 2022
27th Jul 20222:38 pmRNSHolding(s) in Company
7th Jul 20227:00 amRNSTrading Update and Notice of Results
11th Apr 20227:00 amRNSHayward Tyler Secures Nuclear Contracts worth $7m
6th Apr 202212:59 pmRNSExercise of Options and Total Voting Rights
29th Mar 20225:13 pmRNSPDMR Dealing
21st Mar 20227:00 amRNSEnergy Steel Secures Nuclear Contract worth $4.1m
17th Mar 20227:00 amRNSContract Wins
23rd Feb 20227:00 amRNSDirectorate Change
23rd Feb 20227:00 amRNSInterim Results
20th Jan 20227:00 amRNSTrading Update, Notice of Results and Investment
29th Nov 20215:57 pmRNSEmployee & PDMR Share Incentive Awards
22nd Nov 20212:32 pmRNSExercise of Options, PDMR Dealings and TVR
18th Nov 202112:41 pmRNSResult of AGM
13th Oct 20217:00 amRNSInvestment in emerging medtech leader, Adaptix
29th Sep 20217:00 amRNSPreliminary Results for the year ended 31 May 2021
12th Aug 202112:20 pmRNSExercise of Options and Total Voting Rights
12th Jul 202110:51 amRNSExercise of Options, PDMR Dealings and TVR
12th Jul 20217:00 amRNSAvingtrans’ businesses nuclear contract
8th Jul 20217:00 amRNSTrading Update and Notice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.